Multimodal Coregistration in Patients with Temporal Lobe Epilepsy—Results of Different Imaging Modalities in Lateralization of the Affected Hemisphere in MR Imaging Positive and Negative Subgroups

References

1. ↵
   Knowlton RC. The role of FDG-PET, ictal SPECT, and MEG in the epilepsy surgery evaluation. Epilepsy Behav 2006;8:91–101

   CrossRefPubMedWeb of Science
2. ↵
   Knowlton RC, Laxer KD, Ende G, et al. Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy. Ann Neurol 1997;42:829–37

   CrossRefPubMedWeb of Science
3. ↵
   Duncan JS. Imaging and epilepsy. Brain 1997;120:339–77

   Abstract/FREE Full Text
4. ↵
   Berkovic SF, McIntosh AM, Kalnins RM, et al. Preoperative MRI predicts outcome of temporal lobectomy: an actuarial analysis. Neurology 1995;45:1358–63

   Abstract/FREE Full Text
5. ↵
   Jack CR Jr. Epilepsy: surgery and imaging. Radiology 1993;189:635–46

   CrossRefPubMedWeb of Science
6. Stefan H, Feichtinger M, Pauli E, et al. Magnetic resonance spectroscopy and histopathological findings in temporal lobe epilepsy. Epilepsia 2001;42:41–46

   CrossRefPubMed
7. ↵
   Yun CH, Lee SK, Lee SY, et al. Prognostic factors in neocortical epilepsy surgery: multivariate analysis. Epilepsia 2006;47:574–79

   CrossRefPubMedWeb of Science
8. ↵
   Park SW, Chang KH, Kim HD, et al. Lateralizing ability of single-voxel proton MR spectroscopy in hippocampal sclerosis: comparison with MR imaging and positron emission tomography. AJNR Am J Neuroradiol 2001;22:625–31

   Abstract/FREE Full Text
9. Achten E, Santens P, Boon P, et al. Single-voxel proton MR spectroscopy and positron emission tomography for lateralization of refractory temporal lobe epilepsy. AJNR Am J Neuroradiol 1998;19:1–8

   Abstract
10. Gaillard WD, Bhatia S, Bookheimer SY, et al. FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. Neurology 1995;45:123–26

    Abstract/FREE Full Text
11. Van PW, Dupont P, Van DG, et al. SPECT perfusion changes during complex partial seizures in patients with hippocampal sclerosis. Brain 2003;126:1103–11

    Abstract/FREE Full Text
12. ↵
    Hammen T, Stefan H, Eberhardt KE, et al. Clinical applications of 1H-MR spectroscopy in the evaluation of epilepsies–what do pathological spectra stand for with regard to current results and what answers do they give to common clinical questions concerning the treatment of epilepsies? Acta Neurol Scand 2003;108:223–38

    CrossRefPubMed
13. ↵
    Cendes F, Li LM, Watson C, et al. Is ictal recording mandatory in temporal lobe epilepsy? Not when the interictal electroencephalogram and hippocampal atrophy coincide. Arch Neurol 2000;57:497–500

    CrossRefPubMedWeb of Science
14. ↵
    Stefan H, Pawlik G, Bocher-Schwarz HG, et al. Functional and morphological abnormalities in temporal lobe epilepsy: a comparison of interictal and ictal EEG, CT, MRI, SPECT and PET. J Neurol 1987;234:377–84

    CrossRefPubMedWeb of Science
15. ↵
    Engel J Jr, Van Ness PC, Rasmussen T, et al. Outcome with respect to epileptic seizures. In: Engel J Jr, ed. Surgical Treatment of the Epilepsies, 2nd ed. New York: Raven Press;1993 :609–22
16. ↵
    Stefan H, Wang Y, Pauli E, et al. A new approach in anti-epileptic drug evaluation. Eur J Neurol 2004;11:467–73

    CrossRefPubMed
17. ↵
    Hammen T, Stadlbauer A, Tomandl B, et al. Short TE single-voxel 1H-MR spectroscopy of hippocampal structures in healthy adults at 1.5 Tesla–how reproducible are the results? NMR Biomed 2005;18:195–201

    CrossRefPubMed
18. ↵
    Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–79

    CrossRefPubMedWeb of Science
19. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001;14:260–64

    CrossRefPubMedWeb of Science
20. ↵
    Helms G. A precise and user-independent quantification technique for regional comparison of single volume proton MR spectroscopy of the human brain. NMR Biomed 2000;13:398–406

    CrossRefPubMed
21. ↵
    Pataraia E, Lurger S, Serles W, et al. Ictal scalp EEG in unilateral mesial temporal lobe epilepsy. Epilepsia 1998;39:608–14

    CrossRefPubMedWeb of Science
22. ↵
    Soreni N, Noseworthy MD, Cormier T, et al. Intraindividual variability of striatal ¹H-MRS brain metabolite measurements at 3 T. Magn Reson Imaging 2006;24:187–94

    CrossRefPubMed
23. ↵
    Duc CO, Trabesinger AH, Weber OM, et al. Quantitative 1H MRS in the evaluation of mesial temporal lobe epilepsy in vivo. Magn Reson Imaging 1998;16:969–79

    CrossRefPubMedWeb of Science
24. ↵
    Lee DH, Gao FQ, Rogers JM, et al. MR in temporal lobe epilepsy: analysis with pathologic confirmation. AJNR Am J Neuroradiol 1998;19:19–27

    Abstract
25. ↵
    Van PW, Connelly A, Johnson CL, et al. The amygdala and intractable temporal lobe epilepsy: a quantitative magnetic resonance imaging study. Neurology 1996;47:1021–31

    Abstract/FREE Full Text
26. ↵
    Ryvlin P, Philippon B, Cinotti L, et al. Functional neuroimaging strategy in temporal lobe epilepsy: a comparative study of 18FDG-PET and 99mTc-HMPAO-SPECT. Ann Neurol 1992;31:650–56

    CrossRefPubMedWeb of Science
27. Swartz BE, Brown C, Mandelkern MA, et al. The use of 2-deoxy-2-[¹⁸F]fluoro-d-glucose (FDG-PET) positron emission tomography in the routine diagnosis of epilepsy. Mol Imaging Biol 2002;4:245–52

    CrossRefPubMed
28. ↵
    Riederer F, Bittsansky M, Schmidt C, et al. ¹H magnetic resonance spectroscopy at 3 T in cryptogenic and mesial temporal lobe epilepsy. NMR Biomed 2006
29. ↵
    Cendes F, Andermann F, Dubeau F, et al. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology 1997;49:1525–33

    Abstract/FREE Full Text
30. ↵
    Kuzniecky R, Hugg JW, Hetherington H, et al. Relative utility of 1H spectroscopic imaging and hippocampal volumetry in the lateralization of mesial temporal lobe epilepsy. Neurology 1998;51:66–71

    Abstract/FREE Full Text
31. ↵
    Woermann FG, McLean MA, Bartlett PA, et al. Short echo time single-voxel 1H magnetic resonance spectroscopy in magnetic resonance imaging-negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis. Ann Neurol 1999;45:369–76

    CrossRefPubMedWeb of Science
32. ↵
    Petroff OA, Rothman DL, Behar KL, et al. Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures. Seizure 1999;8:120–27

    CrossRefPubMedWeb of Science
33. ↵
    Jack CR, Jr., Mullan BP, Sharbrough FW, et al. Intractable nonlesional epilepsy of temporal lobe origin: lateralization by interictal SPECT versus MRI. Neurology 1994;44:829–36

    Abstract/FREE Full Text
34. ↵
    Stefan H, Bauer J, Feistel H, et al. Regional cerebral blood flow during focal seizures of temporal and frontocentral onset. Ann Neurol 1990;27:162–66

    CrossRefPubMedWeb of Science
35. Shen W, Lee BI, Park HM, et al. HIPDM-SPECT brain imaging in the presurgical evaluation of patients with intractable seizures. J Nucl Med 1990;31:1280–84

    Abstract/FREE Full Text
36. ↵
    Duncan R, Patterson J, Roberts R, et al. Ictal/postictal SPECT in the pre-surgical localisation of complex partial seizures. J Neurol Neurosurg Psychiatry 1993;56:141–48

    Abstract/FREE Full Text
37. ↵
    Zubal IG, Spencer SS, Imam K, et al. Difference images calculated from ictal and interictal technetium-99m-HMPAO SPECT scans of epilepsy. J Nucl Med 1995;36:684–89

    Abstract/FREE Full Text
38. ↵
    O’Brien TJ, So EL, Mullan BP, et al. Subtraction ictal SPECT co-registered to MRI improves clinical usefulness of SPECT in localizing the surgical seizure focus. Neurology 1998;50:445–54

    Abstract/FREE Full Text
39. ↵
    Savic I, Thomas AM, Ke Y, et al. In vivo measurements of glutamine + glutamate (Glx) and N-acetyl aspartate (NAA) levels in human partial epilepsy. Acta Neurol Scand 2000;102:179–88

    CrossRefPubMed
40. ↵
    Petroff OA, Errante LD, Rothman DL, et al. Glutamate-glutamine cycling in the epileptic human hippocampus. Epilepsia 2002;43:703–10

    CrossRefPubMedWeb of Science
41. ↵
    Benbadis SR, So NK, Antar MA, et al. The value of PET scan (and MRI and Wada test) in patients with bitemporal epileptiform abnormalities. Arch Neurol 1995;52:1062–68

    CrossRefPubMedWeb of Science
42. Blum DE, Ehsan T, Dungan D, et al. Bilateral temporal hypometabolism in epilepsy. Epilepsia 1998;39:651–59

    CrossRefPubMedWeb of Science
43. ↵
    Wong CY, Geller EB, Chen EQ, et al. Outcome of temporal lobe epilepsy surgery predicted by statistical parametric PET imaging. J Nucl Med 1996;37:1094–100

    Abstract/FREE Full Text
44. ↵
    Jack CR, Jr., Sharbrough FW, Cascino GD, et al. Magnetic resonance image-based hippocampal volumetry: correlation with outcome after temporal lobectomy. Ann Neurol 1992;31:138–46

    CrossRefPubMedWeb of Science
45. ↵
    Kim MA, Heo K, Choo MK, et al. Relationship between bilateral temporal hypometabolism and EEG findings for mesial temporal lobe epilepsy: analysis of 18F-FDG PET using SPM. Seizure 2006;15:56–63

    CrossRefPubMed
46. ↵
    Gadian DG, Isaacs EB, Cross JH, et al. Lateralization of brain function in childhood revealed by magnetic resonance spectroscopy. Neurology 1996;46:974–77

    Abstract/FREE Full Text
47. ↵
    Zubler F, Seeck M, Landis T, et al. Contralateral medial temporal lobe damage in right but not left temporal lobe epilepsy: a ¹H magnetic resonance spectroscopy study. J Neurol Neurosurg Psychiatry 2003;74:1240–44

    Abstract/FREE Full Text